Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4036 AL 4050

Management of Alzheimer's disease-An insight of the enzymatic and other novel potential targets

Islam BU, Tabrez S.

Int J Biol Macromol. 2017 Apr;97:700-709. doi: 10.1016/j.ijbiomac.2017.01.076. Epub 2017 Jan 19.

Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial

Reisberg B, Shao Y, Golomb J, Monteiro I, Torossian C, Boksay I, Shulman M, Heller S, Zhu Z, Atif A, Sidhu J, Vedvyas A, Kenowsky S.

Dement Geriatr Cogn Disord. 2017;43(1-2):100-117. doi: 10.1159/000455397. Epub 2017 Jan 26.

Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer's disease

Giménez-Llort L, Ratia M, Pérez B, Camps P, Muñoz-Torrero D, Badia A, Clos MV.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):124-131. doi: 10.1097/FBP.0000000000000292.

Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease

Wu WY, Dai YC, Li NG, Dong ZX, Gu T, Shi ZH, Xue X, Tang YP, Duan JA.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):572-587. doi: 10.1080/14756366.2016.1210139.

Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease

Sreenivasmurthy SG, Liu JY, Song JX, Yang CB, Malampati S, Wang ZY, Huang YY, Li M.

Int J Mol Sci. 2017 Jan 28;18(2):272. doi: 10.3390/ijms18020272.

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease

Chase TN, Farlow MR, Clarence-Smith K.

Neurotherapeutics. 2017 Apr;14(2):405-416. doi: 10.1007/s13311-016-0511-x.

Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview

Kumar A, Singh A, Aggarwal A.

Indian J Exp Biol. 2017 Feb;55(2):63-73.

Potential benefits of phytochemicals against Alzheimer's disease

Wightman EL.

Proc Nutr Soc. 2017 May;76(2):106-112. doi: 10.1017/S0029665116002962. Epub 2017 Feb 1.

Exploration of Various Proteins for the Treatment of Alzheimer's Disease

Islam BU, Zaidi SK, Kamal MA, Tabrez S.

Curr Drug Metab. 2017;18(9):808-813. doi: 10.2174/1389200218666170203110135.

Molecular Targets of Tannic Acid in Alzheimer's Disease

Braidy N, Jugder BE, Poljak A, Jayasena T, Nabavi SM, Sachdev P, Grant R.

Curr Alzheimer Res. 2017;14(8):861-869. doi: 10.2174/1567205014666170206163158.

Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance

Quittot N, Sebastiao M, Bourgault S.

Biochem Cell Biol. 2017 Jun;95(3):329-337. doi: 10.1139/bcb-2016-0236. Epub 2017 Feb 1.

Alzheimer's disease in the zebrafish: where can we take it?

Caramillo EM, Echevarria DJ.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):179-186. doi: 10.1097/FBP.0000000000000284.

The contribution of transgenic and nontransgenic animal models in Alzheimer's disease drug research and development

Mhillaj E, Cuomo V, Mancuso C.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):95-111. doi: 10.1097/FBP.0000000000000296.

Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's disease

Franco R, Martínez-Pinilla E, Navarro G, Zamarbide M.

Prog Neurobiol. 2017 Feb-Mar;149-150:21-38. doi: 10.1016/j.pneurobio.2017.01.004. Epub 2017 Feb 9.

The approach and management of bruxism in Alzheimer's disease: An under-recognized habit that concerns caregivers (innovative practice)

Mathew T, Venkatesh S, Srinivas M.

Dementia (London). 2020 Feb;19(2):461-463. doi: 10.1177/1471301217694249. Epub 2017 Feb 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias